[Early internal treatment of mild depression].
In the early 1970s, a number of observers hypothesized that there had been an increase in mild depression in the United State. Interest in mild depression had increased in the world. One manifestation of that interest was the decision in previous official Nomenclatures of WHO and APA to create separate category for affective disorders in the DSM-III. Patients of mild depression complain mainly of physical symptom, for example, headache, lumbago, abdominal pain, dizziness, sleep disturbance, appetite loss. Early internal treatment of mild depression consists of three factors, rest, antidepressants and psychosocial supports. Up to date, the first choice of antidepressants in SSRI. SSRI has antidepressive effect and less side effect than TCA.
Kuboki
T
T
Department of Psychosomatic Medicine, Faculty of Medicine, University of Tokyo.
D003863:Depression / Q000145:classification / Q000453:epidemiology / Q000628:therapy*; D016666:Fluvoxamine / Q000627:therapeutic use; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D017374:Paroxetine / Q000627:therapeutic use; D010821:Physicians, Family; D012017:Referral and Consultation; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D012720:Severity of Illness Index; D012944:Social Support; D000092864:Suicide Prevention
D016666:Fluvoxamine; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors